Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balanced HES 130/0.4 in Severe Burn Injury
NCT01012648Phase 4Unknown
- Sponsor
- University of Zurich
- Start
- Nov 2009
- Primary completion
- Jan 2013
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hetastarch in burn injury, sponsored by University of Zurich. Status: unknown.
02
Drugs
hetastarch
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT01012648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01012648.